ARTIS Ventures recently led a $15M Series A into Luminate Medical, led by Aaron Hannon. We're excited at their potential to transform the chemotherapy treatment process by reducing side effects for patients, lowering costs for payers, and unlocking value for private practice oncologists across the United States. Welcome to the Artis portfolio family!
Announcing the future of cancer treatment: delivering cancer therapies at home. Super excited to reveal Luminate Medical's $15m Series A led by ARTIS Ventures, with participation from Metaplanet, Lachy Groom and 8VC, alongside some excellent angel investors and our existing investors SciFounders and Faber. We're able to announce this funding off the back of successful clinical results using our technologies to prevent hair loss and peripheral neuropathy during chemotherapy. This round marks a big shift for Luminate: it allows us to pursue our vision of delivering cancer treatment at home. Building on our technologies to prevent the side effects of cancer treatment, we're working on new products to help deliver low-risk anti-cancer treatments and pre-treatment procedures outside of the clinic. We want to help patients spend more time at home, and physicians spend more time focused on high value procedures that make a real impact on patient outcomes. A huge thanks to our amazing team at Luminate: including founders Barbara Oliveira and Martin OHalloran, our fantastic management team Ellen Cahill, PhD, Aaron McCormack, EMMET FRAWLEY and newly added Conor Macken, and our super talented R&D, Clinical, Quality and Ops groups. I'm super lucky to work with all of you. Also a big thanks to everyone who has supported us, old and new - especially Matt Krisiloff, Alexander Schubert, Alexandre Barbosa, Sofia Santos, Niall McEvoy, Barry Regan, Austin Walne, Vasudev Bailey and so many more. There are too many to mention, but you know who you are! https://lnkd.in/ecDmn-CX